SE304513B - - Google Patents

Info

Publication number
SE304513B
SE304513B SE27767A SE27767A SE304513B SE 304513 B SE304513 B SE 304513B SE 27767 A SE27767 A SE 27767A SE 27767 A SE27767 A SE 27767A SE 304513 B SE304513 B SE 304513B
Authority
SE
Sweden
Application number
SE27767A
Inventor
A Gagneux
F Haefliger
C Eugster
Original Assignee
Geigy Ag J R
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geigy Ag J R filed Critical Geigy Ag J R
Publication of SE304513B publication Critical patent/SE304513B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/12Oxygen atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE27767A 1963-12-06 1967-01-09 SE304513B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH1495463A CH427803A (de) 1963-12-06 1963-12-06 Verfahren zur Herstellung eines neuen Isoxazolderivates

Publications (1)

Publication Number Publication Date
SE304513B true SE304513B (de) 1968-09-30

Family

ID=4405150

Family Applications (3)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04
SE27767A SE304513B (de) 1963-12-06 1967-01-09
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SE1469364A SE301652B (de) 1963-12-06 1964-12-04

Family Applications After (1)

Application Number Title Priority Date Filing Date
SE27667A SE303507B (de) 1963-12-06 1967-01-09

Country Status (12)

Country Link
US (1) US3242190A (de)
AT (2) AT250348B (de)
BE (1) BE656759A (de)
CH (1) CH427803A (de)
DE (1) DE1445848A1 (de)
DK (4) DK106733C (de)
ES (5) ES306820A1 (de)
FR (2) FR1427775A (de)
GB (1) GB1034939A (de)
IL (1) IL22568A (de)
NL (1) NL6414138A (de)
SE (3) SE301652B (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL130992C (de) * 1964-09-14
DK150615C (da) * 1982-10-26 1987-11-09 Cheminova As Fremgangsmaade til fremstilling af substituerede 3-isoxazololer
AU2002215160A1 (en) 2000-11-30 2002-06-11 Pfizer Products Inc. Combination of gaba agonists and aldose reductase inhibitors
BR0115783A (pt) 2000-11-30 2003-09-16 Pfizer Prod Inc Combinação de agonistas de gaba e inibidores de sorbitol desidrogenase
WO2004100992A2 (en) * 2003-05-16 2004-11-25 Pfizer Products Inc. Therapeutic combinations of atypical antipsychotics with gaba modulators, anticonvulsants or benzodiazapines
PL1691811T3 (pl) 2003-12-11 2014-12-31 Sunovion Pharmaceuticals Inc Skojarzenie leku uspokajającego i modulatora neuroprzekaźnikowego oraz sposoby poprawy jakości snu i leczenia depresji
EP1737466A1 (de) * 2004-01-29 2007-01-03 Pfizer Products Inc. KOMBINATION VON Y-AMINOBUTTERSÄURE-MODULATOREN UND 5HT-1b REZEPTOR-ANTAGONISTEN
EP1928437A2 (de) 2005-08-26 2008-06-11 Braincells, Inc. Neurogenese mittels muscarinrezeptormodulation
EP2258359A3 (de) 2005-08-26 2011-04-06 Braincells, Inc. Neurogenese durch Modulation des Muscarinrezeptors mit Sabcomelin
JP2009512711A (ja) 2005-10-21 2009-03-26 ブレインセルス,インコーポレイティド Pde阻害による神経新生の調節
WO2007053596A1 (en) * 2005-10-31 2007-05-10 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
EP1991212A1 (de) * 2006-03-08 2008-11-19 Braincells, Inc. Neurogenesemodulation durch nootropika
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
US20100009983A1 (en) * 2006-05-09 2010-01-14 Braincells, Inc. 5 ht receptor mediated neurogenesis
EP2026813A2 (de) 2006-05-09 2009-02-25 Braincells, Inc. 5-ht-rezeptor-vermittelte neurogenese
WO2007134136A2 (en) 2006-05-09 2007-11-22 Braincells, Inc. Neurogenesis by modulating angiotensin
WO2008030651A1 (en) * 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20080103165A1 (en) * 2006-09-19 2008-05-01 Braincells, Inc. Ppar mediated modulation of neurogenesis
WO2010099217A1 (en) 2009-02-25 2010-09-02 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations

Also Published As

Publication number Publication date
US3242190A (en) 1966-03-22
ES306817A1 (es) 1965-05-16
DE1445848A1 (de) 1968-11-21
FR4139M (de) 1966-05-02
DK108169C (da) 1967-10-02
NL6414138A (de) 1965-06-07
CH427803A (de) 1967-01-15
ES306818A1 (es) 1965-05-16
DK106733C (da) 1967-03-13
BE656759A (de) 1965-06-08
ES306816A1 (es) 1965-05-16
FR1427775A (fr) 1966-02-11
AT250348B (de) 1966-11-10
DK106797C (da) 1967-03-20
GB1034939A (en) 1966-07-06
SE301652B (de) 1968-06-17
SE303507B (de) 1968-09-02
DK106796C (da) 1967-03-20
AT249054B (de) 1966-09-26
IL22568A (en) 1968-04-25
ES306819A1 (es) 1965-05-16
ES306820A1 (es) 1965-05-16

Similar Documents

Publication Publication Date Title
AT260747B (de)
BE627012A (de)
BE626938A (de)
BE31062A (de)
BE462764A (de)
BE465565A (de)
BE507458A (de)
BE533484A (de)
BE547422A (de)
BE571209A (de)
BE582314A (de)
BE603935A (de)
BE608372A (de)
BE612803A (de)
BE614220A (de)
BE616247A (de)
BE616830A (de)
BE616967A (de)
BE627025A (de)
BE620325A (de)
BE621232A (de)
BE621517A (de)
BE622160A (de)
BE623117A (de)
BE623220A (de)